Anexas Pharmaceuticals Private Limited, a active private limited company, was established on 26 November 2019 in Agra, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999UP2019PTC123830. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.00 M.
It upholds a compliant status. Its leadership includes Monika Saxena (Director), Ajeet Kumar Saxena (Director), Sujeet Kumar Saxena (Director). Past directors included Monika Saxena, Devansh Saxena, Pankhuri Saxena. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at D-9, Jai Ram Bagh, Nagla Baghel, Dayal Bagh,, Agra, Uttar Pradesh, 282005.
U74999UP2019PTC123830
123830
26 November 2019
₹7.50 M
₹7.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Anexas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monika Saxena | Director | 29 May 2020 | Current |
| Ajeet Kumar Saxena | Director | 26 Nov 2019 | Current |
| Sujeet Kumar Saxena | Director | 26 Nov 2019 | Current |
| Anupama Saxena | Director | 26 Nov 2019 | Current |
| Devansh Saxena | Director | 28 Apr 2022 | Current |
| Divya Saxena | Director | 28 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anexas Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 41.58% increase. The company also saw a substantial improvement in profitability, with a 129.84% increase in profit. The company's net worth moved up by a moderate rise of 7.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Anexas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2020 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Anexas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Anexas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anexas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Anexas Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Anexas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.
The activity A charge with Others of Rs. 10.00 M registered on 08 Sep 2020 with Charge ID 100371671 was modified on 21 Sep 2022. was completed.
Devansh Saxena was appointed as a Director was appointed as a Director on 28 Apr 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Divya Saxena was appointed as a Director was appointed as a Director on 28 Apr 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 10.00 M with Charge ID 100371671 was registered on 08 Sep 2020. was documented.
The CIN of Anexas Pharmaceuticals Private Limited is U74999UP2019PTC123830.
Anexas Pharmaceuticals Private Limited is headquartered at D-9, Jai Ram Bagh, Nagla Baghel, Dayal Bagh,, Agra, Uttar Pradesh, 282005.
Anexas Pharmaceuticals Private Limited was incorporated on 26 November 2019.
The current directors of Anexas Pharmaceuticals Private Limited are
The primary industry of Anexas Pharmaceuticals Private Limited is Trade.
Anexas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Anexas Pharmaceuticals Private Limited is ₹7.50 M, and the paid-up capital is ₹7.00 M.
The compliance status of Anexas Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX